Dr. Boris Ovodenko, MD

Dr. Ovodenko practices at South Florida Eye Institute in Tamarac, Florida.

Dr. Ovodenko's NPI, 1598813750, was assigned on January 6, 2007. Dr. Ovodenko graduated from SUNY Downstate Health Sciences University in 2001. Dr. Ovodenko holds Florida license ME103168.

Dr. Ovodenko's primary practice is South Florida Eye Institute, at 6233 N University Dr, Tamarac, FL 33321. The practice phone is (954) 721-0000.

Dr. Ovodenko's primary practice is South Florida Eye Institute in Tamarac, Florida. Dmand AI also links Dr. Ovodenko to 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Ovodenko's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ovodenko practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Ovodenko's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Ovodenko is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Ovodenko's licenses on file in 6 states: Florida, California, Connecticut, New York, Pennsylvania and New Jersey.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Ovodenko treats.

CMS data shows 711 Medicare services from Dr. Ovodenko across 12 procedure codes in 2024, for 291 Medicare patients. Medicare paid $49,974 for them. Every service was in an office.

CMS counts 291 Medicare patients who saw Dr. Ovodenko in 2024. The largest group is 75 to 84, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ovodenko's median patient age at 71, with 62% women.

In 2024, Dr. Ovodenko wrote 795 Medicare Part D claims for 270 patients. 66% of them were for generic drugs. CMS names the drug for 726 of them, across 11 drugs with 11 or more claims each, at $41,124 in total drug cost. In 2023, CMS named 1,353 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Ovodenko for performance year 2024, reported as part of a group. Dr. Ovodenko accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of cataract surgery by Dr. Ovodenko, more than 39% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Ovodenko. Dr. Ovodenko's most frequent co-authors are Jeffrey M. Liebmann, MD, Aimee S. Payne, MD, PhD and Michael Y. Wang, MD.

CMS Open Payments shows 38 general payments to Dr. Ovodenko from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $297.

Dmand AI lists 3 awards for Dr. Ovodenko, most recently Phizer fellow in 2005.

Dr. Ovodenko graduated from SUNY Downstate Health Sciences University in 2001.

Dr. Ovodenko is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.